Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
1.
Hand (N Y) ; 19(1): 175-179, 2024 01.
Artigo em Inglês | MEDLINE | ID: mdl-38149769

RESUMO

PURPOSE: Concern exists that Medicare physician fees for procedures have decreased over the past 20 years. The Centers for Medicare & Medicaid Services (CMS) is set to re-evaluate these physician fees in the near future for concern that these procedures are overvalued. Our study sought to analyze trends in Medicare reimbursement rates from 2000 to 2019 for the top 20 most billed hand and upper extremity surgical procedures at our institution. METHODS: The financial database of a single academic tertiary care center was queried to identify the Current Procedural Terminology codes most frequently utilized in orthopedic hand and upper extremity procedures in 2019. The Physician Fee Schedule Look-Up Tool from the CMS was queried for annual physician fee data. Monetary data were adjusted for inflation using the consumer price index of Urban Research Series (CPI-U-RS) and expressed in 2019 constant US dollars (USD). The average annual and total percent change in reimbursement were calculated via linear regression for all procedures (P < .05). RESULTS: Accounting for inflation, the total average physician reimbursement decreased by 20.9% from 2000 to 2019, with 12 of 20 codes decreasing by more than 20%. The greatest decrease pertained to arthrodesis of the wrist at 33.9%. Upon linear regression, all procedures were found to decrease annually, with arthrodesis of the wrist decreasing by an average of 2.3% annually over this period. CONCLUSIONS: Over the past 2 decades, physician reimbursement for hand and upper extremity procedures has significantly decreased.


Assuntos
Reembolso de Seguro de Saúde , Medicare , Idoso , Estados Unidos , Humanos , Extremidade Superior/cirurgia , Mãos/cirurgia , Punho
2.
Expert Opin Biol Ther ; 20(12): 1503-1513, 2020 12.
Artigo em Inglês | MEDLINE | ID: mdl-32845168

RESUMO

OBJECTIVES: The aim of this study was to evaluate the safety and efficacy of the use of FG-SVFs in face rejuvenation for esthetic improvement. METHODS: 33 female patients affected by face's soft-tissue defects with loss of volume, study group (SG), were treated with FG-SVFs, comparing results with a control group (CG) (n = 30) treated with fat graft not enhanced (FG). Clinical evaluation, a photographic assessment, magnetic resonance imaging (MRI), and ultrasound (US) were performed. Post-operative follow-up was performed at 1, 3, 7, 12, 24, 48, weeks, and then annually. RESULTS: SG patients showed 61% maintenance of the contour restoring and of volume after 3 years compared with the CG treated with FG, who showed 31% maintenance. 60.7% (n = 20) of SG patients, presented an increase of 6.6 mm in the soft tissue volume after 36 months, which was reported in only 33,3% (n = 10) of the CG. Volumetric persistence in the SG was higher than that in the CG (p <. 0001 vs. CG). MRI and US moreover confirmed the absence of important side effects, as fat necrosis, and cytosteatonecrotic areas. CONCLUSIONS: The use of FG-SVFs was safe and effective in this series of a case treated.


Assuntos
Tecido Adiposo/irrigação sanguínea , Tecido Adiposo/transplante , Procedimentos de Cirurgia Plástica/métodos , Rejuvenescimento/fisiologia , Ritidoplastia/métodos , Células Estromais/transplante , Tecido Adiposo/citologia , Adulto , Idoso , Estudos de Coortes , Face/fisiologia , Feminino , Sobrevivência de Enxerto/fisiologia , Humanos , Pessoa de Meia-Idade , Satisfação do Paciente , Estudos Retrospectivos , Células Estromais/fisiologia , Adulto Jovem
3.
Ann Plast Surg ; 63(2): 201-5, 2009 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-19571738

RESUMO

The aim of this meta-analysis was to collect data from randomized trials in burn patients and to analyze them with a meta-analytic approach to give a clear message of potential advantages of nanocrystalline silver (NC) versus older silver formulations (SS). A review of all-English prospective randomized trials that compared NC versus silver sulfadiazine or silver nitrate was conducted. Primary outcome was the evaluation of differences in the infection rate of burns. Secondary outcomes were the eventual differences in the pain experienced during medications, the length of hospitalization (LOS) and costs. Five articles that met the inclusion criteria were selected (n = 285 patients). The NC group had a significant lower incidence of infections compared with the SS group (9.5% vs. 27.8%, odds ratio: 0.14 [95% CI: 0.06-0.35]; chi2 test, P < 0.001), with a 2.9-fold decrease of the risk. Not all studies investigated the pain during change of dressings, LOS and costs. However, when data were available, these showed lower costs (US $1533 per patient for the SS group and US $946 per patient for the NC group) and decreased pain values in the NC group (Hedges' G: -1.44 [95% CI: -1.86/-1.01]; P < 0.0001), while contrasting results were obtained for LOS. Nanocrystalline silver is a relatively new product with a significant stronger antimicrobial activity compared with older formulations. Its long lasting properties reduce dressing change frequency and are probably responsible for the decreased pain and the minor costs experienced.


Assuntos
Queimaduras/tratamento farmacológico , Prata/uso terapêutico , Cicatrização/efeitos dos fármacos , Administração Tópica , Distribuição de Qui-Quadrado , Medicina Baseada em Evidências , Humanos , Nanopartículas , Avaliação de Resultados em Cuidados de Saúde , Ensaios Clínicos Controlados Aleatórios como Assunto , Prata/administração & dosagem
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA